Hennion & Walsh Asset Management, Inc. Horizon Therapeutics Public LTD CO Transaction History

Hennion & Walsh Asset Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $2.81 Million - $3.13 Million	-32,622 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $2.34 Million - $3.11 Million	32,622 New	32,622 $3 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.